287.67
1.04%
2.97
After Hours:
287.67
Insulet Corporation stock is traded at $287.67, with a volume of 486.81K.
It is up +1.04% in the last 24 hours and up +7.18% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
See More
Previous Close:
$284.70
Open:
$284.78
24h Volume:
486.81K
Relative Volume:
0.89
Market Cap:
$20.18B
Revenue:
$1.98B
Net Income/Loss:
$420.90M
P/E Ratio:
49.26
EPS:
5.84
Net Cash Flow:
$218.20M
1W Performance:
+2.73%
1M Performance:
+7.18%
6M Performance:
+46.51%
1Y Performance:
+44.10%
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
287.67 | 20.18B | 1.98B | 420.90M | 218.20M | 5.84 |
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-06-24 | Initiated | Bernstein | Outperform |
May-30-24 | Initiated | Redburn Atlantic | Buy |
May-07-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
Oct-18-22 | Initiated | Barclays | Equal Weight |
Oct-12-22 | Initiated | Jefferies | Hold |
Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
Mar-02-22 | Resumed | BofA Securities | Buy |
Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
Feb-02-22 | Upgrade | UBS | Neutral → Buy |
Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
Jul-21-21 | Resumed | Cowen | Outperform |
May-25-21 | Initiated | Barclays | Overweight |
Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
Jul-28-20 | Initiated | Wells Fargo | Overweight |
Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-03-20 | Initiated | BofA/Merrill | Neutral |
Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
Mar-05-20 | Initiated | Citigroup | Buy |
Dec-10-19 | Initiated | CFRA | Sell |
Oct-23-19 | Initiated | Stifel | Hold |
Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
Oct-04-19 | Downgrade | UBS | Buy → Neutral |
Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
Apr-20-18 | Initiated | Berenberg | Buy |
Feb-22-18 | Reiterated | Barclays | Overweight |
Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Insulet Co. (NASDAQ:PODD) Stock Position Reduced by Pacer Advisors Inc. - MarketBeat
If EPS Growth Is Important To You, Insulet (NASDAQ:PODD) Presents An Opportunity - Yahoo Finance
Why Insulet Corporation (NASDAQ:PODD) Looks Like A Quality Company - Simply Wall St
Sargent Investment Group LLC Takes Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
abrdn plc Cuts Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Jennison Associates LLC - MarketBeat
Swedbank AB Has $14.02 Million Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Mediolanum International Funds Ltd Has $2.34 Million Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Forsta AP Fonden Lowers Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Zacks.com featured highlights NVIDIA, AppLovin and Insulet - Yahoo Finance
Here's Why You Should Add PODD Stock to Your Portfolio Now - MSN
RFG Advisory LLC Takes Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Head-To-Head Contrast: Insulet (NASDAQ:PODD) & PROCEPT BioRobotics (NASDAQ:PRCT) - Defense World
Insulet stock soars to 52-week high, reaches $282.87 By Investing.com - Investing.com Nigeria
Earnings Preview: What to Expect From Insulet's Report - MSN
Insulet stock soars to 52-week high, reaches $282.87 - MSN
Insulet Co. (NASDAQ:PODD) Stock Position Raised by Nisa Investment Advisors LLC - Defense World
(PODD) Investment Report - Stock Traders Daily
Insulet (NASDAQ:PODD) Reaches New 52-Week HighHere's What Happened - MarketBeat
Earnings Preview: What To Expect From Insulet's Report - Barchart
913 Shares in Insulet Co. (NASDAQ:PODD) Acquired by CX Institutional - MarketBeat
AEGON ASSET MANAGEMENT UK Plc Sells 7,189 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Earnings Not Telling The Story For Insulet Corporation (NASDAQ:PODD) - Simply Wall St
Geneos Wealth Management Inc. Has $7.87 Million Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
SG Americas Securities LLC Grows Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Insulet post-verdict discovery requests are unnecessary, unwarranted, EOFlow says - MLex
Insider Selling: Insulet Co. (NASDAQ:PODD) EVP Sells 12,394 Shares of Stock - MarketBeat
Jury Awards $452 Million After Trade Secrets Trial - JD Supra
Donoghue Forlines LLC Acquires Shares of 7,812 Insulet Co. (NASDAQ:PODD) - MarketBeat
Whalen Wealth Management Inc. Takes Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Beacon Investment Advisory Services Inc. Decreases Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet stock hits 52-week high at $281.99 amid robust growth - Investing.com Australia
Diversify Wealth Management LLC Purchases 935 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet (NASDAQ:PODD) Reaches New 12-Month HighShould You Buy? - MarketBeat
AMI Asset Management Corp Sells 3,405 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Sax Wealth Advisors LLC Acquires 1,532 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
6,742 Shares in Insulet Co. (NASDAQ:PODD) Purchased by Avanza Fonder AB - MarketBeat
(PODD) Investment Analysis - Stock Traders Daily
Assenagon Asset Management S.A. Has $27.25 Million Stock Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
GEHC or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Contravisory Investment Management Inc. Takes $552,000 Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
USA Financial Formulas Makes New Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):